# Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

> **NCT00660894** · PHASE3 · COMPLETED · sponsor: **Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan** · enrollment: 1535 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** folinate calcium
- **DRUG:** tegafur-uracil
- **DRUG:** tegafur-gimeracil-oteracil potassium

## Key facts

- **NCT ID:** NCT00660894
- **Lead sponsor:** Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-06
- **Final completion:** 2015-07
- **Target enrollment:** 1535 (ACTUAL)
- **Last updated:** 2016-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660894, "Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00660894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*